Education
About Us
Working with TipRanks
Follow Us
CytomX Therapeutics Inc. (CTMX)
NASDAQ:CTMX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 138.10M | $ 101.21M | $ 53.16M | $ 37.31M | $ 68.43M |
| Gross Profit | $ 138.10M | $ 101.21M | $ 53.16M | $ 37.31M | $ 68.43M |
| Operating Income | $ 25.00M | $ -6.48M | $ -101.33M | $ -116.04M | $ -80.54M |
| EBITDA | $ 26.76M | $ -4.31M | $ -98.89M | $ -113.34M | $ -77.97M |
| Net Income | $ 31.87M | $ -569.00K | $ -99.32M | $ -115.87M | $ -64.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 100.62M | $ 174.51M | $ 193.65M | $ 305.23M | $ 316.12M |
| Total Assets | $ 120.53M | $ 201.79M | $ 260.89M | $ 339.41M | $ 358.66M |
| Total Debt | $ 9.38M | $ 13.97M | $ 18.06M | $ 21.67M | $ 24.87M |
| Net Debt | $ -28.67M | $ -3.20M | $ -175.59M | $ -183.86M | $ -166.99M |
| Total Liabilities | $ 120.99M | $ 249.24M | $ 346.64M | $ 339.87M | $ 366.44M |
| Stockholders' Equity | $ -456.00K | $ -47.45M | $ -85.75M | $ -459.00K | $ -7.77M |
| Cash Flow | |||||
| Free Cash Flow | $ -86.54M | $ -56.88M | $ -112.53M | $ -120.64M | $ 2.95M |
| Operating Cash Flow | $ -86.23M | $ -56.03M | $ -110.79M | $ -119.03M | $ 5.26M |
| Investing Cash Flow | $ 99.70M | $ -150.67M | $ 98.26M | $ 22.49M | $ -18.72M |
| Financing Cash Flow | $ 7.52M | $ 30.23M | $ 648.00K | $ 110.21M | $ 16.89M |